TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Kashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Webinar on pharma production

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Tribune News Service

Advertisement

Chandigarh, May 29

Advertisement

The Indian Pharmaceutical Association (IPA), Panjab branch, in association with the University Institute of Pharmaceutical Sciences and DST funded Technology Enabling Centre, Panjab University, organised a webinar on “Pharmaceutical Production Excellence in Regulatory Scenario”.

Prof OP Katare, president, IPA, Punjab branch, emphasised the need for quality production of drugs under high pressure global regulations.

Prof VR Sinha, Dean University Instruction, highlighted India’s contribution to the global generics.

Advertisement

Prof Sinha stressed upon the immense opportunity for India to take a leapfrog using the impetus provided by Covid-19 and play the role of “pharmacy of the world”.

Advertisement
Show comments
Advertisement